+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Colon Cancer Drugs Market Research Reports

From
Colon Cancer Treatment Drugs Markets in China - Product Thumbnail Image

Colon Cancer Treatment Drugs Markets in China

  • Report
  • May 2020
  • 199 Pages
From
From
Colon Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Colon Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • June 2018
  • 782 Pages
From
Colon Carcinoma - Pipeline Insights, 2017 - Product Thumbnail Image

Colon Carcinoma - Pipeline Insights, 2017

  • Drug Pipelines
  • January 2017
  • 60 Pages
From
CAS 63121-00-6 Oxaliplatin Chemical World Report - Product Thumbnail Image

CAS 63121-00-6 Oxaliplatin Chemical World Report

  • Report
  • June 2020
  • 2160 Pages
CAS 61825-94-3 Oxaliplatin Chemical World Report - Product Thumbnail Image

CAS 61825-94-3 Oxaliplatin Chemical World Report

  • Report
  • June 2020
  • 2024 Pages
CAS 59-05-2 Methotrexate Chemical World Report - Product Thumbnail Image

CAS 59-05-2 Methotrexate Chemical World Report

  • Report
  • June 2020
  • 2111 Pages
CAS 97682-44-5 Irinotecan Chemical World Report - Product Thumbnail Image

CAS 97682-44-5 Irinotecan Chemical World Report

  • Report
  • June 2020
  • 2079 Pages
CAS 51-21-8 5-Fluorouracil Chemical World Report - Product Thumbnail Image

CAS 51-21-8 5-Fluorouracil Chemical World Report

  • Report
  • June 2020
  • 2054 Pages
CAS Methotrexate World Consumption Report - Product Thumbnail Image

CAS Methotrexate World Consumption Report

  • Report
  • June 2020
  • 2095 Pages
CAS 5-Fluorouracil World Consumption Report - Product Thumbnail Image

CAS 5-Fluorouracil World Consumption Report

  • Report
  • June 2020
  • 2079 Pages
From
From
Loading Indicator

Colon (or colorectal/bowel cancer) is diagnosed in over 1 million people annually, and accounts for over 0.5 million deaths each year. According to a recent article in the renowned Lancet medical journal, in Europe the 5-year survival for colorectal cancer is less than 60% so there is certainly considerable market potential for effective and accessible new pharmaceutical drugs. Reports in the Colon Cancer Section will help industry operators, and those considering entering this market, to answer the key questions such as what are the latest clinical trials, what are the R&D trends, what is the potential for personalized medicine, where are the opportunities in major markets such as China and the US, etc. Show Less Read more

adroll